October 2017
Tania Rivera Hernandez > Other Awards
Award given as part of the 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases, for the work presented at that event.
June 2018
Tania Rivera Hernandez > Other Awards
Award given by the Australian Society for Medical Research at the Queensland Awards for Health & Medical Research for the work carried out towards the development of a group A Streptococcus vaccine.
January 2017
Tania Rivera Hernandez > Other Awards
Award given by the Sistema Nacional de Investigadores in Mexico. Award is valid for three years and has been re-awarded for the 2020-2022 period.
Degrees:
2013
Doctorate
Other
Publications resulting from Research
Rivera-Hernandez T., Walker M. Humanized Plasminogen Mouse Model to Study Group A Streptococcus Invasive Disease. In: Proft T., Loh J. (eds) Group A Streptococcus. Methods in Molecular Biology, vol 2136. Humana, New York, NY, 2020.
Xu Z., Rivera-Hernandez T., Moyle P. Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein–Fusion Combination Vaccine. ACS Infectious Diseases, 6, 7, 1770–1782, 2020.
Rivera-Hernandez T., Rhyme M. S., Cork A. J., Jones S., Segui-Perez C., Brunner L., Richter J., Petrovsky N., Lawrenz M., Goldblatt D., Collin N., Walker M. J. Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies. mBio 11 (2), 2020.
Rivera-Hernandez T., Carnathan D. G., Jones S., Cork A. J., Davies M. R., Moyle P., Toth I., Batzloff M. R., McCarthy J., Nizet V., Goldblatt D., Silvestri G., Walker M. J. An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model. mBio 10 (2), 2019.
Rivera-Hernandez T., Pandey M., Henningham A., Cole J., Choudhury B., Cork A. J., Gillen C. M., Ghaffar K. A., West N. P., Silvestri G., Good M. F., Moyle P. M., Toth I., Nizet V., Batzloff M. R., Walker M. J. Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models. mBio 7(3), 2016.
Barnett T.C., Cole J.N., Rivera‐Hernandez T., Henningham A., Paton J.C., Nizet V., Walker M.J. Streptococcal toxins: role in pathogenesis and disease. Cellular microbiology 17 (12), 2015.
Rivera-Hernandez T., Carnathan D. G., Moyle P., Toth I., West N. P., Young P. R., Silvestri G., Walker M. J. The contribution of non-human primate models to the development of human vaccines. Discovery Medicine 18(101), 2014.
Chuan, Y.P., Rivera-Hernandez, T., Wibowo, N., Connors, N.K.,Wu, Y., Hughes, F.K., Lua, L.H., Middelberg, A.P. Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine. Biotechnology and Bioengineering 110 (9) 2013.
Rivera-Hernandez, T., Hartas, J., Wu, Y., Chuan, Y.P., Lua, L.H.L., Good, M., Batzloff, M.R., Middelberg, A.P.J. Self-adjuvanting modular virus-like particles for mucosal vaccination against group A Streptococcus (GAS). Vaccine 31 (15) 2013.
Middelberg, A.P.J., Rivera-Hernandez, T., Wibowo, N., Lua, L.H.L., Fan, Y., Magor, G., Chang, C., Chuan, Y.P., Good, M., Batzloff, M.R. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine 29 (41), September 2011, pp. 7154-7162.
Lorne Infection and Immunity Conference
2025
Evaluation of leading group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive murine models of disease.
20th Lancefield International Symposium on Streptococci and Streptococcal Diseases
2025
Efficacy of a non-M protein GAS vaccine in a primate model of pharyngitis and tonsillitis
Vaccinology course
2025
Lorne Infection and Immunity Conference
2025
20th Lancefield International Symposium on Streptococci and Streptococcal Diseases
2025
BactiVac Annual Meeting
2025